Lanean...

Open label study of ambrisentan in patients with exercise pulmonary hypertension

A growing body of evidence suggests that exercise pulmonary hypertension (ePH) is an early form of pulmonary arterial hypertension (PAH). Identifying the disease at an early, potentially more responsive phase, and initiating treatment may improve functional status and prevent progression to severe f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pulm Circ
Egile Nagusiak: Segrera, Sergio A., Lawler, Laurie, Opotowsky, Alexander R., Systrom, David, Waxman, Aaron B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2017
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467947/
https://ncbi.nlm.nih.gov/pubmed/28597763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217709024
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!